International Stem Cell (ISCO) Accounts Payables (2010 - 2026)

International Stem Cell (ISCO) has reported Accounts Payables for 17 consecutive years, with $310000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables fell 21.91% year-over-year to $310000.0 in Q2 2026; TTM through Jun 2026 was $310000.0, a 21.91% decrease from a year earlier, with the FY2025 full-year figure at $168000.0, down 9.68% from the prior year.
• Accounts Payables was $310000.0 for Q2 2026 at International Stem Cell, up from $168000.0 in the prior quarter.
• Over five years, Accounts Payables peaked at $635000.0 in Q1 2022 and troughed at $168000.0 in Q4 2025.
• A 5-year average of $353058.8 and a median of $351000.0 in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables plunged 48.9% in 2024 and rose 26.94% in 2025, its largest moves.
• Over 5 years, Accounts Payables stood at $322000.0 in 2022, then advanced by 13.04% to $364000.0 in 2023, then tumbled by 48.9% to $186000.0 in 2024, then declined by 9.68% to $168000.0 in 2025, then surged by 84.52% to $310000.0 in 2026.
• The last three Accounts Payables figures came in at $310000.0 (Q2 2026), $168000.0 (Q4 2025), and $265000.0 (Q3 2025), per Business Quant data.